Abstract
The occurrence of pharmaceutical substances and its migration in aquatic ecosystems has recently raised a serious public concern as well as relevant environmental issues all over the world. The main objective of the research was to perform the flow analysis of the investigated substances and to provide recommendations on how to reduce pollution of the selected pharmaceuticals in Lithuania.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Transforming our world: the 2030 Agenda for Sustainable Development. Resolution adopted by the General Assembly on 25 September 2015
The European Green Deal. Communication from the Commission to the European Parliament, the European Council, the Council, the European Economic and Social committee and the Committee of the Regions. Brussels, 11.12.2019 COM(2019) 640 final
Communication from the Commission to the European Parliament, the Council, the European economic and social committee and the committee of the regions. Pathway to a Healthy Planet for All EU Action Plan: ‘Towards Zero Pollution for Air, Water and Soil’. Brussels, 12.5.2021 COM(2021) 400 final
EC: Commission Implementing Decision (EU) 2018/840 of 5 June 2018 establishing a watch list of substances for Union-wide monitoring in the field of water policy pursuant to Directive 2008/105/EC of the European Parliament and of the Council and repealing Comm. Off. J. Eur. Union L 141(October 2000), 9–12 (2018)
Communication from the Commission to the European Parliament, the Council and the European economic and social committee. European Union Strategic Approach to Pharmaceuticals in the Environment. Brussels, 3 March, 2019. COM 2019 (128)
Regulation (EU) No 1235/2010 of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance of medicinal products for human use, Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, and Regulation (EC) No 1394/2007 on advanced therapy medicinal products, OJ L 348, 31.12.2010, p. 1; Directive 2010/84/EU of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use, OJ L 348, 31.12.2010, p. 74
Communication from the Commission to the European Parliament, the Council and the European economic and social committee. European Union Strategic Approach to Pharmaceuticals in the Environment. Brussels, 11.3.2019 COM(2019) 128 final
Ben, Y., Caixia, F., Min, H., Liu, L., Wong, M.H., Zheng, C.: Human health risk assessment of antibiotic resistance associated with antibiotic residues in the environment: a review. Environ. Res. 169, 483–493 (2019)
Islas-Espinoza, M., Aydin, S., de las Heras, S., Ceron, C.A., Martínez, S.G., Vázquez-Chagoyán, J.C.:Sustainable bioremediation of antibacterials, metals and pathogenic DNA in water. J. Cleaner Prod. 183, 112–120 (2018)
Eurobarometer, Special Eurobarometer 478: Antimicrobial Resistance, November 2016
Determination of the Regional Pharmaceutical Burden in 15 Selected WWTPs and Associated Water Bodies using Chemical Analysis. Status in four coastal regions of the South Baltic Sea Germany, Lithuania, Poland and Sweden. Project MORPHEUS 2017–2019, p. 126 (2020)
Jessick, A.M.: Detection, fate, and bioavailability of erythromycin in environmental matrices, pp. 1–99 (2010)
Aydin, S., Aydin, M.E., Ulvi, A., Kilic, H.: Antibiotics in hospital effluents: occurrence, contribution to urban wastewater, removal in a wastewater treatment plant, and environmental risk assessment. Environ. Sci. Pollut. Res. 26(1), 544–558 (2018). https://doi.org/10.1007/s11356-018-3563-0
Acknowledgement
This research was developed in the framework of the INTERREG EUROPE programme project “Improving the European Rivers Water Quality through Smart Water Management Policies - BIGDATA4RIVERS” funded by the EU’s European Regional Development fund through the INTERREG EUROPE, 2014–2020.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this paper
Cite this paper
Beigaite, R., Baranauskaite-Fedorova, I., Dvarioniene, J. (2021). Assessment and Management of Pharmaceutical Substances in the Environment. In: Gervasi, O., et al. Computational Science and Its Applications – ICCSA 2021. ICCSA 2021. Lecture Notes in Computer Science(), vol 12950. Springer, Cham. https://doi.org/10.1007/978-3-030-86960-1_55
Download citation
DOI: https://doi.org/10.1007/978-3-030-86960-1_55
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-86959-5
Online ISBN: 978-3-030-86960-1
eBook Packages: Computer ScienceComputer Science (R0)